TTrialPathMatch Me to Trials
← Back to trials
RecruitingParoxysmal Atrial FibrillationPersistent Atrial FibrillationVentricular Arrhythmia

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

Eligible age

18+ yrs

Accepts

All genders

Locations

31 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The primary purpose of this Registry is to assess procedural safety and long-term effectiveness of catheter ablations in the treatment of subjects with PAF, PsAF, and VA. The Registry will utilize real world clinical data obtained from the use of commercially available CARTO™ technologies under the authority of a health care practitioner within a legitimate practitioner-subject relationship. Data from the registry will be used to assess clinical outcomes, including procedural efficiency, safety, and long-term effectiveness of catheter ablation with novel technologies for arrhythmia patients.

Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

You may qualify if…

  • Symptomatic PAF (AF episode terminate spontaneously within 7 days) or PsAF (AF sustained beyond 7 days, but less than 365 days) subjects who, in the opinion of the investigator, are candidates for catheter ablation.
  • \>18 years of age.
  • Will be treated with Biosense Webster Inc. ablation technologies
  • All AF ablations performed with BWI catheters are included. This includes repeat ablations where the index procedure was performed with a non-BWI catheter.
  • Able and willing to participate in baseline and follow up evaluations
  • Willing and able to provide informed consent, if applicable.
  • Documented ventricular arrhythmia appropriate for catheter ablation.
  • \>18 years of age.

You may not qualify if…

  • Enrolled in an investigational drug or device clinical trial, or any trial that dictates the treatment plan
  • Long-standing persistent AF (AF greater than one year)
  • In the opinion of the investigator, any known contraindication to an ablation procedure
  • CORE VA Cohort
  • Enrolled in an investigational drug or device clinical trial, or any trial that dictates the treatment plan.
  • In the opinion of the investigator, any known contraindication to an ablation procedure.

Where it's recruiting

Alabama

Birmingham · Mobile

Arizona

Chandler · Tucson

Arkansas

Jonesboro

California

Los Angeles · Santa Barbara · Ventura · Walnut Creek

Colorado

Aurora · Golden · Littleton

Florida

Jacksonville · Miami · Naples · Pensacola

Georgia

Atlanta · Savannah

Hawaii

Honolulu

Illinois

Evanston · Naperville · Springfield

Indiana

Indianapolis

Iowa

Iowa City

Kentucky

Louisville · Saint Matthews

Source: ClinicalTrials.gov · NCT04088071 · last updated 2026-07-09

Real-world Experience of Catheter Ablation for the Treatment of Arrhyt · TrialPath